Enact Holdings (ACT) Stock News

Genworth Financial (NYSE: GNW) will release third-quarter results after market close on November 4, 2026, ahead of its earnings call.

Genworth’s call is scheduled for November 5 at 10:00 a.m. ET. Its publicly traded subsidiary, Enact Holdings (Nasdaq: ACT), will discuss its third-quarter results that day at 8:00 a.m. ET. Genworth’s earnings release, summary presentation and financial supplement will be available on its investor website.

Enact Holdings (ACT) has entered into a forward quota share reinsurance agreement through its flagship subsidiary, Enact Mortgage Insurance Corporation.

Under the agreement, and subject to certain conditions, Enact will transfer approximately 35% of a portion of expected new insurance written from January 1, 2028 through December 31, 2028. Quota share reinsurance transfers a specified share of insurance risk to reinsurers. Each participating reinsurer is currently rated A- or better by Standard & Poor’s or A.M. Best, or A3 or better by Moody’s. Enact describes the agreement as a step in advancing its credit risk transfer program and managing and distributing risk.

Genworth (GNW) introduced a new Family Caregiver Benefit that allows eligible long-term care insurance policyholders in certain states to use coverage for qualified care provided by family members. The benefit is accessed through a voluntary coverage election, under which policyholders may modify certain policy features in exchange for using benefits when family members deliver care. When qualified care is provided, the benefit can pay up to 75% of the median hourly cost for non-medical care, based on the current annual CareScout Cost of Care Survey. The program is expected to roll out state by state following regulatory approvals.

Enact Holdings (ACT) received an upgrade from AM Best on the insurance financial strength ratings of Enact Mortgage Insurance Corporation and Enact Mortgage Insurance Corporation of North Carolina, raised to A from A-.

AM Best also upgraded Enact Holdings’ long-term issuer rating to bbb from bbb-, with a stable outlook on all ratings. The company’s CEO said this is the first AM Best upgrade since coverage began in 2023 and reflects Enact’s continued strong performance and capital position.

Genworth Financial (GNW) issued a response on September 15, 2026 to a UK Court of Appeal ruling in AXA’s case against Santander over historic Payment Protection Insurance (PPI) liabilities.

The Court of Appeal granted Santander’s appeal, setting aside most of the trial court’s judgment that had favored AXA on its indemnity claim, and rejected AXA’s appeal on a contribution claim. The judgment results in Santander being found not liable for the vast majority of AXA’s losses linked to historic PPI mis-selling complaints. Genworth’s CEO Tom McInerney said the company is reviewing the decision and working with AXA to consider next steps, including possible further appeals. He added that no recoveries from this case had been included in Genworth’s capital allocation plans, and emphasized continued focus on Enact, CareScout growth, and maintaining self-sustainability in the Closed Block.

Genworth Financial (GNW) expanded its existing share repurchase program by an additional $500 million as approved by its Board of Directors.

As of September 1, 2026, about 30 million shares had been repurchased for approximately $262 million under the prior $350 million authorization, leaving about $88 million available. The expansion increases total authorization to $850 million. Repurchases are expected to be funded from current holding company cash and future cash flows from Genworth’s ownership in Enact Holdings. The program has no expiration date and may be carried out via open-market or privately negotiated transactions, including Rule 10b5-1 plans, subject to market conditions and other factors.

Enact (Nasdaq: ACT) reported second quarter 2026 GAAP net income of $175 million, or $1.25 per diluted share, and adjusted operating income of $177 million, or $1.26 per diluted share. Return on equity was 13.0%, with adjusted operating ROE of 13.2%.

New insurance written reached $15 billion, up 19% sequentially and 15% year over year, while primary insurance in-force rose to $274 billion. Net premiums earned were $245 million and the loss ratio was 14%. Book value per share was $39.06, or $39.66 excluding AOCI.

The company reported PMIERs sufficiency of 161%, or about $1.9 billion above requirements. Enact paid a $0.24 per share dividend (~$34 million), repurchased about 2.2 million shares for $93 million, and raised full-year 2026 capital return guidance to $550–$600 million. The board declared a new $0.24 quarterly dividend, payable September 17, 2026.

Genworth Financial (NYSE: GNW) reported Q2 2026 net income of $47 million, or $0.12 per diluted share, and adjusted operating income excluding Closed Block of $112 million, or $0.29 per diluted share. Results were led by majority-owned Enact Holdings (Nasdaq: ACT), which delivered adjusted operating income of $143 million.

Enact’s primary new insurance written reached $15.2 billion, up 19% versus Q1 and 15% year-over-year, with a loss ratio of 14% and a PMIERs sufficiency ratio of 161%, or $1.894 billion above requirements. Genworth’s legacy insurance companies reported a consolidated RBC ratio of 286%.

Genworth ended the quarter with $215 million of holding company cash and liquid assets and received $103 million of capital returns from Enact. The company repurchased $62 million of shares in Q2 and $918 million since program inception through June 30, 2026. Closed Block adjusted operating loss widened to $110 million, driven by a $127 million pre-tax actual-to-expected loss in long-term care.

Enact (Nasdaq: ACT) will release its second quarter 2026 earnings after market close on August 5, 2026 and host an earnings conference call on August 6, 2026 at 8:00 a.m. ET.

Materials and the webcast will be available on Enact's investor relations website.